V B Grinevich studies the condition known as ulcerative colitis, which is an inflammatory bowel disease that causes long-lasting inflammation and ulcers in the digestive tract. His research primarily investigates new treatment methods to help patients manage their symptoms more effectively. One significant focus of his work is on propionyl-L-carnitine, a compound that seems to enhance treatment outcomes for patients who are already on stable oral medication for ulcerative colitis. He aims to provide alternative solutions that may lead to better symptom management and overall health.
Key findings
In a clinical trial, 72% of patients taking propionyl-L-carnitine reported a positive response to treatment compared to 50% in the placebo group.
The treatment was generally safe, with the majority of side effects being related to the stomach.
Patients receiving propionyl-L-carnitine showed a noticeable improvement in symptoms of ulcerative colitis.
Frequently asked questions
Does Dr. Grinevich study ulcerative colitis?
Yes, Dr. Grinevich focuses specifically on ulcerative colitis and seeks to develop better treatment options for patients.
What treatments has Dr. Grinevich researched?
Dr. Grinevich has researched propionyl-L-carnitine as a treatment for patients with ulcerative colitis who are already on stable medication.
Are Dr. Grinevich's findings relevant to my ulcerative colitis?
Yes, his findings regarding propionyl-L-carnitine could provide additional therapy options for managing your ulcerative colitis symptoms.
Publications in plain English
[Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians].
2022
Terapevticheskii arkhiv
Simanenkov VI, Maev IV, Tkacheva ON, Alekseenko SA, Andreev D +25 more
Plain English This paper reviews guidelines for doctors on how to protect the gut lining in patients with related diseases. The experts identified 28 practical recommendations, focusing on treatments like proton pump inhibitors, bismuth drugs, and probiotics, showing that rebamipide is a key medication for protecting the gut. This matters because improving gut health can lead to better overall health for patients with multiple health issues.
Who this helps: Patients with gastrointestinal conditions and their doctors.
Effect of Prebiotic Complex on Gut Microbiota and Endotoxemia in Female Rats with Modeled Heart Failure.
2020
Bulletin of experimental biology and medicine
Vlasov AA, Shperling MI, Terkin DA, Bystrova OV, Osipov GA +2 more
Plain English This study looked at the impact of a prebiotic supplement on gut health in female rats with heart failure. Researchers found that the levels of harmful bacteria and toxins in the blood were higher in the rats with heart failure, but these levels dropped significantly after they were treated with the prebiotic complex. This is important because it shows that the prebiotic can help improve gut health and reduce toxin levels in heart failure, suggesting it could be a useful treatment option.
Who this helps: Patients with heart failure.
[Gut microbiota and systemic inflammation in patients with chronic heart failure].
2020
Kardiologiia
Vlasov AA, Salikova SP, Grinevich VB, Bystrova OV, Osipov GA +1 more
Plain English This study looked at the connection between chronic inflammation and gut bacteria in patients with chronic heart failure (CHF). Researchers found that patients with more severe symptoms of CHF had higher inflammation levels, as indicated by C-reactive protein levels and specific markers like NT-proBNP. Notably, patients with CHF had fewer beneficial gut bacteria and higher levels of harmful ones, which could be linked to their worsening condition.
Who this helps: This helps patients with chronic heart failure and their doctors by highlighting the potential role of gut health in managing their condition.
Russian consensus on exo- and endocrine pancreatic insufficiency after surgical treatment.
2018
Terapevticheskii arkhiv
Khatkov IE, Maev IV, Abdulkhakov SR, Alekseenko SA, Alikhanov RB +30 more
Plain English This research focused on understanding how to diagnose and treat issues with the pancreas after surgery, specifically when it fails to produce important hormones and enzymes. Experts came together to agree on best practices, emphasizing the importance of teamwork between gastroenterologists and surgeons. These guidelines help ensure better patient care and management following pancreatic surgery.
Who this helps: Patients recovering from pancreatic surgery.
[The Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapy].
2017
Terapevticheskii arkhiv
Khatkov IE, Maev IV, Bordin DS, Kucheryavyi YA, Abdulkhakov SR +42 more
Plain English This research focused on how doctors in Russia diagnose and treat chronic pancreatitis, particularly emphasizing enzyme replacement therapy, which helps patients whose bodies do not produce enough digestive enzymes. The study brought together experts from various medical fields to unify their approaches and share best practices, which is vital since nearly 80% of patients with chronic pancreatitis experience poor digestion that can severely impact their quality of life. This standardization matters because it can lead to more consistent and effective patient care across the country.
Who this helps: Patients suffering from chronic pancreatitis and their healthcare providers.
Human gut microbiota community structures in urban and rural populations in Russia.
2013
Nature communications
Tyakht AV, Kostryukova ES, Popenko AS, Belenikin MS, Pavlenko AV +26 more
Plain English This study examined the gut bacteria of 96 healthy adults in Russia from both urban and rural areas to understand how their microbiomes differ. Researchers found that rural populations have unique gut bacteria communities that are healthier, predominantly featuring two major groups of bacteria, Bacteroidetes and Firmicutes. These differences are likely influenced by the diet, culture, and socioeconomic status of people in these regions, highlighting the importance of these factors in gut health.
Who this helps: This helps healthcare providers and researchers understand how environment and lifestyle affect gut health in different populations.
[Chronic pancreatitis: microbe-intestinal tissue complex and systemic inflammatory response].
2011
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology
Grinevich VB, Sas EI, Denisov NL, Efimov OI
Plain English This study focused on patients with chronic pancreatitis, a condition that is becoming more common in Russia but is difficult to treat effectively. Researchers found that a combination of therapies, including medication to reduce stomach acid, relieve spasms, and support gut health with prebiotics, significantly decreased inflammation and improved treatment outcomes. Specifically, adding prebiotics helped balance gut bacteria and reduced overall inflammation in these patients.
Who this helps: This helps patients with chronic pancreatitis by providing a more effective treatment approach.
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.
2011
Alimentary pharmacology & therapeutics
Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG +15 more
Plain English In this study, researchers looked at the effects of propionyl-L-carnitine (PLC) on patients with mild-to-moderate ulcerative colitis (UC) who were already stable on treatment. They found that 72% of patients taking PLC had a positive response to treatment, compared to 50% in the placebo group, showing that PLC may help improve symptoms. The treatment was generally safe, with side effects mostly related to the stomach.
Who this helps: This helps patients with ulcerative colitis looking for better management options.
[VIII Congress of Russian Gastroenterological Scientific Society. XXXIV Session of the Central Research Institute of Gastroenterology (4-7 March, 2008, Moscow). Standards "Diagnosis and therapy of acid-dependent diseases including Helicobacter pylori-associated diseases" (Third Moscow Agreement, 04.02.05 with supplements adopted on 06.03.08 by VIII Congress of Russian Gastroenterological Scientific Society)].
2008
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology
, Bredikhina NA, Butov MA, Vasil'ev IuV, Golovanova ES +22 more
Plain English This study looked at how well a treatment called thioctic acid (also known as alpha-lipoic acid) works in patients with alcoholic hepatitis, focusing on 61 individuals with an average age of about 42. The researchers found that using this treatment helped reduce liver damage and inflammation, which was shown by improved liver enzyme levels and changes in the liver’s structure. This finding is important because it highlights a potential way to better treat and manage alcoholic hepatitis, helping to prevent further liver damage.
Who this helps: This helps patients suffering from alcoholic hepatitis.
[New prospects in treating chronic pancreatitis (clinico-pharmacoeconomic study)].
2003
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology
Grinevich VB, Ivanikov IO, Uspenskiĭ IuP, Lasyĭ VP, Shcherbina NN +1 more
Plain English This research looked at different surgical methods for treating inguinal hernias, a common condition where tissue bulges through a weak spot in the groin. Findings showed that no single surgery completely prevents hernias from coming back, but a careful choice of technique—based on the surgeon's experience and the materials used—can lead to better outcomes. This matters because it highlights the importance of personalized treatment plans to improve recovery for patients.
Who this helps: Patients undergoing surgery for inguinal hernias.
[Characteristics of non-Helicobacter pylori ulcer disease].
2002
Terapevticheskii arkhiv
Grinevich VB, Uspenskiĭ IuP, Shabanova GZh, Shcherbina NN
Plain English This study looked at ulcer disease in patients to understand how it differs for those infected with Helicobacter pylori (HP) compared to those who are not. Among 411 patients, 338 were found to have HP, while the remaining had unique psychological and physical symptoms. Adding mental health medications to standard ulcer treatments helped these patients recover faster and improved their quality of life.
Who this helps: This benefits patients with non-HP related ulcers.
[Pharmacotherapy of non-associated with Helicobacter pylori ulcer].
2002
Klinicheskaia meditsina
Grinevich VB, Uspenskiĭ IuP, Shabanova GZh, Sablin OA, Shcherbina NN
Plain English This study looked at 77 patients with ulcers that were not caused by a bacteria called Helicobacter pylori. The researchers found that treating these patients with famotidine, followed by either phosphalugel for duodenal ulcers or de-nol for gastric ulcers, was more effective than using ranitidine. This treatment helped patients stay ulcer-free and had fewer side effects.
Who this helps: This benefits patients suffering from ulcers that aren't linked to Helicobacter pylori.
[Acid-base blood balance in patients with ulcer under treatment by the gastric secretion inhibitors and antacids].
2002
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology
Grinevich VB, Sablin OA, Uspenskiĭ IuL
Plain English Researchers studied 25 patients with duodenal ulcers to see how different medications affected their stomach acidity and the acid-base balance in their blood. After two weeks of treatment with drugs like omeprazole or famotidine, significant changes were observed; for example, the majority of patients showed improved acid-base balance. This is important because managing acidity can lead to better healing of ulcers and overall health.
Who this helps: This helps patients with duodenal ulcers and their doctors in choosing effective treatments.
[Acute and chronic gastroduodenal erosions: characteristics of etiology, pathogenesis, clinical aspects and diagnosis].
1994
Klinicheskaia meditsina
Grinevich VB, Uspenskiĭ IuP, Vologzhanin DA, Grigor'ev EP, Kalinin AV
Plain English This study looked at 2,620 patients with various health issues and found that 252 had acute stomach and gut erosions, while 178 had chronic ones. The researchers discovered that chronic erosions were often linked to problems with blood circulation and liver function, affecting about 75% of those cases. Understanding these connections is important for doctors to better diagnose and treat these conditions.
Who this helps: This helps patients with stomach and gut issues and their doctors.
[Dyspepsia of a nonulcerous nature in servicemen under conditions of ecological-occupational stress].
1994
Voenno-meditsinskii zhurnal
Grinevich VB, Uspenskiĭ IuP, Melkumov SP
Plain English This study looked at servicemen who had non-ulcer dyspepsia, a digestive issue that causes discomfort without the presence of ulcers, often caused by stressful work environments. Researchers found that these servicemen suffered from changes in the lining of the stomach and small intestine, indicating underlying damage, while some had problems with how their stomach and intestines move food along. This matters because understanding these symptoms can lead to better care and treatment for affected servicemen.
Who this helps: This helps servicemen with digestive issues related to their stressful work conditions.
[The course of the reparative process in patients with gastric and duodenal peptic ulcers (a clinico-statistical study)].
1993
Terapevticheskii arkhiv
Grinevich VB, Tkachenko EI, Uspenskiĭ IuP
Plain English This study looked at the healing process in 332 patients with stomach ulcers and 294 patients with duodenal ulcers. Researchers found that the size and location of the ulcer, along with factors like stomach acid levels and smoking habits, significantly impacted how well the ulcers healed. These findings are important because they can help doctors tailor treatments to improve recovery for patients with these types of ulcers.
Who this helps: This helps patients with gastric and duodenal ulcers, as well as their doctors.
[The dynamic functional-morphological changes in the small intestine of obese patients undergoing weight-reducing diet therapy].
1992
Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova
Tkachenko EI, Luft VM, Grukhin IuA, Grinevich VB, Pershko AM
Plain English This study looked at 28 obese patients undergoing a weight-loss diet and found that their small intestine showed two main types of changes during fasting: one involved structural changes in the lining of the intestine that reduced cell growth, and the other involved inflammation with increased immune cell presence. By the 26th day of following the diet, their intestinal lining had fully recovered. This is important because it shows that a diet can restore gut health in obese patients.
Who this helps: Patients who are obese and seeking to improve their gut health through diet.
[The specificity of the peripheral blood changes in patients with gastric peptic ulcer].
1991
Vrachebnoe delo
Tkachenko EI, Ivashkin VT, Grinevich VB, Kovalenko VI, Vologzhanin DA
Plain English This study looked at the white blood cells (leucocytes) in 112 patients with stomach ulcers to see how their levels changed over time. Researchers found that the number and type of white blood cells in the blood changed in phases as the ulcer healed. This matters because understanding these changes can help doctors better monitor and treat patients with stomach ulcers.
Who this helps: This helps doctors and patients with gastric ulcers.
[Erosive changes of the gastroduodenal mucosa--is it a pre-ulcer state?].
1991
Klinicheskaia meditsina
Grinevich VB, UspenskiI IuP, Grigor'ev EP, Kalinin AV
Plain English This study looked at 280 patients with ulcers and found that 107 of them had erosive gastritis, duodenitis, or gastroduodenitis, which are early signs that could lead to ulcers. The researchers found that the type and location of these erosions, as well as the body's response to them and how it processes nutrients, play a role in developing ulcers. Understanding these early changes is important because it could help prevent ulcers from forming in the first place.
Who this helps: Patients at risk of developing ulcers.
[A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
1989
Terapevticheskii arkhiv
Ivashkin VT, Tkachenko EI, Grinevich VB, Sultanov VK, Inozemtsev SA
Plain English This study looked at how effective different treatments were for peptic ulcers, comparing sucralfate to other medications like cimetidine, ranitidine, and antacids. The results showed that sucralfate completely healed ulcers in all patients after 5 weeks, while ranitidine healed 90%, cimetidine healed 84%, and antacids and cholinolytics healed 78%. This matters because it highlights sucralfate as a highly effective option for treating ulcers, potentially leading to better care for patients.
Who this helps: Patients suffering from peptic ulcers.
[Functional and morphological status of the gastric mucosa mast cells on the administration of dimedrol and suprastin].
1983
Farmakologiia i toksikologiia
Uspenskiĭ VM, Zelenyĭ VA, Grinevich VB, Fokina AA
Plain English This study looked at how two antihistamines, dimedrol and suprastin, affect mast cells in the stomach and small intestine of rats over 45 days. The researchers found that these medications boosted the activity of mast cells, leading to more new mast cells forming and older ones breaking down faster. This is important because it helps us understand how antihistamines might influence stomach health and immune response.
Who this helps: This helps patients with stomach issues who may benefit from antihistamine treatment.
[Gastric mucosal mast cells and precancerous states].
1981
Voprosy onkologii
Uspenskiĭ VM, Grinevich VB
Plain English This study examined the presence of mast cells in the stomach lining of 30 gastric cancer patients and 190 patients with precancerous conditions. The researchers found that in patients with chronic atrophic gastritis and persistent ulcers, the number of mast cells was significantly reduced, which also occurred in the gastric cancer patients. This finding is important because it suggests that changes in mast cells could serve as early warning signs of stomach cancer.
Who this helps: This helps patients at risk for stomach cancer and their doctors in identifying precancerous changes early.
[Mast cells as a criterion of repair process activity in ulcerative stomach lesions].
1980
Arkhiv patologii
Uspenskiĭ VM, Grinevich VB
Plain English This study looked at mast cells in patients with stomach ulcers and cancer to see how they relate to healing. It involved 215 patients with peptic ulcers and 23 with gastric cancer. The researchers found that more mast cells were present around healing ulcers, while those in chronic ulcers or cancer showed fewer mast cells, which helps in diagnosing and understanding these conditions.
Who this helps: This helps patients with stomach ulcers and doctors treating them.